01672.HK
Ascletis Pharma Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 4.90
−6.04%Margins
Gross margin
-863.4%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-26.1%
Return on equity
-24.1%
Return on assets
-29.3%
Return on invested capital
0.00x
Asset turnover
-HKD 589.4M
Cash from operations
HKD 2.75
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026